Implementation of Anti-Bip Antibodies as A Novel Biomarker in The Diagnosis of Rheumatoid Arthritis
Keywords:
Rheumatoid arthritis, Anti-Bip, CRP, ESR, Sensitivity, SpecificityAbstract
Background: Anti-BiP antibodies, directed against the binding immunoglobulin protein (BiP), have recently been identified as potential biomarkers in autoimmune diseases such as rheumatoid arthritis (RA). They are involved in ER stress responses and immune dysregulation, pathogenic forces contributing to RA. Methods: In this matched case–control study, 75 established RA cases along with 45 age and sex matched controls attended Al-Hakeem General Hospital, Al-Najaf, Iraq from March 2024 through February 2025. The diagnosis was established according to the 2010 ACR/EULAR classification criteria for RA. Detection of Anti-BiP antibodies in serum was carried out using standardized ELISA method and also serum levels of inflammatory markers (C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) were estimated. Results: The average serum Anti-BiP antibody level was higher in patients with RA (38.7 ± 8.5 U/mL) than in controls (15.2 ± 5.6 U/mL; p < 0.001). There was also a strong positive correlation between Anti-BiP antibodies and CRP levels (r = 0.68, p < 0.001) as well ESRs (r = 0.62, p < 0.001). The ROC curve analysis showed good diagnostic accuracy for the Anti-BiP antibodies (AUC = 0.902, p < 0.001). At the cut-off level of ≥22.3 U/mL, sensitivity and specificity for diagnosis of RA were 72% and 81.5% respectively. Conclusion: Serum Anti-BiP antibody are significantly increased in patients with RA and they are closely associated with inflammation activity. Their high positive diagnostic accuracy demarcates Anti-BiP autoantibodies as a promising new solid-state reliable biomarker for the early diagnosis and clinical estimation of rheumatoid arthritis.
References
Gonzalez-Gronow, M., & Pizzo, S. V. (2022). Physiological roles of the autoantibodies to the 78-kilodalton glucose-regulated protein (GRP78) in cancer and autoimmune diseases. Biomedicines, 10(6), 1222. https://doi.org/10.3390/biomedicines10061222
Li, R., Zhang, Y., Wang, H., & Chen, L. (2024). Serum and urine lipidomic profiles identify biomarkers for seronegative rheumatoid arthritis. Frontiers in Immunology, 15, 1422776. https://doi.org/10.3389/fimmu.2024.1422776
Liu, Y., Wu, J., Shen, G., & Lei, P. (2018). Diagnostic value of BiP or anti-BiP antibodies for rheumatoid arthritis: A meta-analysis. Clinical and Experimental Rheumatology, 36(3), 406–411. https://doi.org/10.55563/cer.180611
Matsueda, Y., Takahashi, H., Nishimura, K., & Iwanaga, N. (2018). Elevation of serum anti-glucose-regulated protein 78 antibodies in autoimmune disease contexts. Lupus Science & Medicine, 5(1), e000276. https://doi.org/10.1136/lupus-2018-000276
Michael, B. N. R., Mariaselvam, C. M., Kavadichanda, C. G., Negi, V. S., et al. (2023). Synovial-fluid-derived microparticles express vimentin and GRP78 in their surface and exhibit an in vitro stimulatory effect on fibroblast-like synoviocytes in rheumatoid arthritis. International Journal of Rheumatic Diseases, 26(11), 2183–2194. https://doi.org/10.1111/1756-185X.14912
Qin, J., He, M., Chen, L., & Zhou, H. (2020). Serological proteome analysis identifies novel autoantibody biomarkers in inflammatory diseases. Evidence-Based Complementary and Alternative Medicine, 2020, 1–9. https://doi.org/10.1155/2020/9264189
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis. The Lancet, 388(10055), 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8
Sokolova, M. V., Schett, G., & Steffen, U. (2022). Autoantibodies in rheumatoid arthritis: Historical background and novel findings. Clinical Reviews in Allergy & Immunology, 63(2), 138–151. https://doi.org/10.1007/s12016-021-08890-1
Sunar, İ., Kaptanoğlu, E., & Yılmaz, H. (2020). Serum C-reactive protein/albumin ratio in rheumatoid arthritis: Relation to disease activity and quality of life. Biomedical Reports, 12(1), 1–6. https://doi.org/10.3892/br.2019.1264
Yu, H.-C., Lai, P.-H., Lai, N.-S., Huang, H.-B., Koo, M., & Lu, M.-C. (2016). Increased serum levels of anti-carbamylated 78-kDa glucose-regulated protein antibody in patients with rheumatoid arthritis. International Journal of Molecular Sciences, 17(9), 1510. https://doi.org/10.3390/ijms17091510
Zaiss, M. M., Hall, C., McGowan, N. W. A., et al. (2019). Binding immunoglobulin protein (BiP) inhibits TNF-α–induced osteoclast differentiation and systemic bone loss in an erosive arthritis model. ACR Open Rheumatology, 1(6), 382–393. https://doi.org/10.1002/acr2.11060
